Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (171-180 of 286) with videos related to

Pageof 29
Sort By:
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|December 13, 2012
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizersYaacov Richard Lawrence, Bhadrasain Vikram, James J Dignam, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Cancer Biology & Therapy|August 7, 2013
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumabNicholas G Zaorsky, Yunguang Sun, Zixuan Wang, et al.
Iscience|April 14, 2019
Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent GrowthRachel M DeRita, Aejaz Sayeed, Vaughn Garcia, et al.
Gastroenterology|November 11, 2008
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancerJames J Farrell, Hany Elsaleh, Miguel Garcia, et al.
Practical Radiation Oncology|September 13, 2015
RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experienceDavid J Hoopes, Adam P Dicker, Nadine L Eads, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical schoolNicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
Pageof 29

Showing results (171-180 of 286) with videos related to

Sort By:
Pageof 29
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|December 13, 2012
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizersYaacov Richard Lawrence, Bhadrasain Vikram, James J Dignam, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Cancer Biology & Therapy|August 7, 2013
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumabNicholas G Zaorsky, Yunguang Sun, Zixuan Wang, et al.
Iscience|April 14, 2019
Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent GrowthRachel M DeRita, Aejaz Sayeed, Vaughn Garcia, et al.
Gastroenterology|November 11, 2008
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancerJames J Farrell, Hany Elsaleh, Miguel Garcia, et al.
Practical Radiation Oncology|September 13, 2015
RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experienceDavid J Hoopes, Adam P Dicker, Nadine L Eads, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical schoolNicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
Pageof 29